BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2091 related articles for article (PubMed ID: 10966468)

  • 1. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ; Wiley DC
    Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure and receptor binding properties of the 1918 influenza hemagglutinin.
    Gamblin SJ; Haire LF; Russell RJ; Stevens DJ; Xiao B; Ha Y; Vasisht N; Steinhauer DA; Daniels RS; Elliot A; Wiley DC; Skehel JJ
    Science; 2004 Mar; 303(5665):1838-42. PubMed ID: 14764886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure and function of the hemagglutinin of influenza viruses].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2562-9. PubMed ID: 9360372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection.
    Mair CM; Ludwig K; Herrmann A; Sieben C
    Biochim Biophys Acta; 2014 Apr; 1838(4):1153-68. PubMed ID: 24161712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
    Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
    Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane fusion by surrogate receptor-bound influenza haemagglutinin.
    Millar BM; Calder LJ; Skehel JJ; Wiley DC
    Virology; 1999 May; 257(2):415-23. PubMed ID: 10329552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.
    Alvarado-Facundo E; Gao Y; Ribas-Aparicio RM; Jiménez-Alberto A; Weiss CD; Wang W
    J Virol; 2015 Feb; 89(4):1975-85. PubMed ID: 25473053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody that prevents the hemagglutinin low pH fusogenic transition.
    Barbey-Martin C; Gigant B; Bizebard T; Calder LJ; Wharton SA; Skehel JJ; Knossow M
    Virology; 2002 Mar; 294(1):70-4. PubMed ID: 11886266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological changes and fusogenic activity of influenza virus hemagglutinin.
    Shangguan T; Siegel DP; Lear JD; Axelsen PH; Alford D; Bentz J
    Biophys J; 1998 Jan; 74(1):54-62. PubMed ID: 9449309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities.
    Zhu X; Yu W; McBride R; Li Y; Chen LM; Donis RO; Tong S; Paulson JC; Wilson IA
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1458-63. PubMed ID: 23297216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T; Epand RF; Epand RM; Blumenthal R
    Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active site for fusion activity of influenza virus hemagglutinin].
    Ohuchi M; Ohuchi R
    Nihon Rinsho; 1997 Oct; 55(10):2648-53. PubMed ID: 9360385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Kadam RU; Wilson IA
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4240-4245. PubMed ID: 29610325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis.
    Leikina E; Markovic I; Chernomordik LV; Kozlov MM
    Biophys J; 2000 Sep; 79(3):1415-27. PubMed ID: 10969003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin.
    Zhou Y; Wu C; Zhao L; Huang N
    Proteins; 2014 Oct; 82(10):2412-28. PubMed ID: 24854389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.